Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Hepatocellular Carcinoma
Intervention: Drug: Adjuvant group
Sponsor: Yonsei University
Completed - verified January 2009
Condition: Leaky Gut Syndrome
Intervention: Dietary Supplement: colostrum
Sponsors: Gangnam Severance Hospital; Cell Biotech Co., Ltd.
Recruiting - verified November 2009
Condition: Advanced Gastric Cancer
Interventions: Procedure: laparoscopy assisted distal gastrectomy; Procedure: open distal gastrectomy
Sponsor: National Cancer Center, Korea
Not yet recruiting - verified March 2010
Condition: Prostatic Cancer
Intervention: Drug: epidural infusion of saline, ropivecaine, or ropivacaine and sufentanil
Sponsor: Yonsei University
Recruiting - verified March 2010
Condition: Kidney Transplant Recipient
Intervention: Drug: Isoniazid treatment
Sponsor: Asan Medical Center
Not yet recruiting - verified March 2010
Conditions: Kidney Neoplasm; Cysts; Carcinoma, Renal Cell
Intervention: Procedure: partial or radical nephrectomy
Sponsor: Seoul National University Hospital
Completed - verified March 2010
Condition: Minimal Change Disease
Intervention: Drug: Tacrolimus
Sponsor: Seoul National University Hospital
Recruiting - verified March 2010
Condition: Coronary Artery Occlusive Disease
Intervention: Drug: ulinastatin, saline solution
Sponsor: Yonsei University
Recruiting - verified March 2010
Condition: CNS Lymphoma
Intervention: Drug: MTX, MVD, VIA
Sponsor: Samsung Medical Center
Recruiting - verified March 2010
Condition: Cardiac Arrest
Interventions: Drug: Use of prophylactic anticonvulsants (valproate, clonazepam); Drug: Control group
Sponsor: Samsung Medical Center
Not yet recruiting - verified March 2010
Conditions: HER2 Positive; Metastatic Breast Cancer
Interventions: Drug: CT-P6; Drug: Herceptin; Drug: Paclitaxel
Sponsor: Celltrion
Recruiting - verified March 2010
Conditions: Advanced Gastric Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: AUY922; Drug: Docetaxel or Irinotecan
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg; Drug: Placebo/sitagliptin 2x50 mg; Drug: Canagliflozin 300 mg
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Thyroidectomy
Intervention: Drug: remifentanil / lidocaine
Sponsor: Yonsei University
Recruiting - verified February 2010
Condition: Hypercholesterolemia
Interventions: Drug: atorvastatin; Drug: atorvastatin
Sponsor: Yonsei University
Completed - verified January 2010
Condition: Colorectal Neoplasms
Intervention: Drug: Erbitux (Cetuximab)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Hypotension After Reperfusion in Liver Transplantation
Interventions: Drug: Phenylephrine; Drug: epinephrine; Drug: placebo control
Sponsor: Seoul National University Hospital
Not yet recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Bisoprolol; Drug: Atenolol
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
Sponsor: Seoul National University Hospital
Completed - verified March 2010
Condition: Coronary Artery Disease
Interventions: Procedure: Cypher, xience, Endeavor, Taxus; Drug: optimal medical therapy
Sponsor: CardioVascular Research Foundation, Korea
Not yet recruiting - verified February 2010
Condition: Persistent Atrial Fibrillation
Intervention: Procedure: radiofrequency catheter ablation
Sponsor: Korea University Anam Hospital
Recruiting - verified January 2010
Condition: Acute Lymphoblastic Leukemia
Intervention:
Sponsor: Samsung Medical Center
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Hypertension
Intervention: Drug: Nebilet
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention: Drug: adalimumab (Humira)
Sponsors: Abbott; Eisai Limited
Enrolling by invitation - verified March 2010
Condition: Neoplasms, Squamous Cell
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Multifollicular Stimulation
Intervention: Drug: Gonal-F (Follitropin alfa)
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Head and Neck Cancer
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Conditions: Thyroidectomy; Distress; Surgery
Intervention:
Sponsor: Korean Association of Endocrine Surgeons
Active, not recruiting - verified February 2010
Condition: Colorectal Neoplasm
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention: Drug: Interferon-β-1a
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Nausea and Vomiting Post Chemotherapy
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Drug: ZD9393 (Zoladex); Drug: ZD9393 (Zoladex)
Sponsor: AstraZeneca
Not yet recruiting - verified February 2010
Condition: Heart Failure, Congestive
Intervention: Drug: Bisoprolol
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Gastroenteritis Rotavirus
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: HIV-1 Infection
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
Sponsor: Abbott
Enrolling by invitation - verified March 2010
Condition: Type 2 Diabetes
Interventions: Behavioral: Lifestyle counseling; Behavioral: Standard care
Sponsor: The Catholic University of Korea
Recruiting - verified December 2007
Condition: Hypertension
Interventions: Drug: Nifedipine (Adalat, BAYA1040) and Valsartan; Drug: Nifedipine (Adalat, BAYA1040); Drug: Valsartan
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Prostate Cancer
Intervention: Drug: Degarelix
Sponsors: Ferring Pharmaceuticals; Ferring Pharmaceuticals Korea, Ltd.
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Breast Cancer
Intervention: Drug: Paclitaxel,Gemcitabine,Sunitinib
Sponsors: National Cancer Center, Korea; Pfizer; CJ Cheiljedang Corporation
Recruiting - verified January 2009
Condition: Hypercholesterolemia
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: Atherosclerosis
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: Prevention
Interventions: Drug: D961H; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified February 2010
Conditions: Myocardial Infarction; Angioplasty
Intervention: Drug: glycoprotein IIb/IIIa inhibitor (abciximab)
Sponsors: Seoul National University Hospital; Seoul National University Bundang Hospital
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Device: PFC-Sigma RP; Device: LPS RP
Sponsor: Ewha Womans University
Completed - verified January 2010
All Locations ... More Countries » ... Korea, South 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
